Hims & Hers Health Inc. buy Guggenheim
Start price
27.02.24
/
50%
€12.65
Target price
27.02.25
€15.66
Performance (%)
-7.47%
Price
19:29
€11.71
Summary
This prediction is currently active. With a performance of -7.47%, the BUY prediction for Hims & Hers Health Inc. by Guggenheim is down slightly. This prediction currently runs until 27.02.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Hims & Hers Health Inc. | 4.566% | 4.566% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by Guggenheim for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Guggenheim from $15.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Stopped prediction by Guggenheim for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€11.00
28.02.23
28.02.23
€14.12
28.02.24
28.02.24
12.73%
29.02.24
29.02.24